Free Newsletter
Allopurinol may lower blood pressure in teens
A medication used to reduce uric acid levels might help lower blood pressure in adolescents if lifestyle modifications don't work or aren't attempted. That's according to a new study published in the Journal of the American Medical Association. In fact, elevated uric acid levels may be the cause of high blood pressure in certain individuals, according to some studies, but since there are several possible causes of higher-than-normal uric acid levels in patients with hypertension, there is no proof of a causal relationship.
The researchers evaluated adolescents, ages 11 to 17 years, who have elevated uric acid levels as well as a new diagnosis of high blood pressure to see if the drug allopurinol would reduce blood pressure.
Although the sample size was very small--just 30 teens in the study--two-thirds of the teens taking allopurinol during the trial showed a reduction in blood pressure to normal levels, whereas only one in 30 did so when taking the placebo medication.
Allopurinol's side effect profile, however, includes Stevens-Johnson syndrome a rare, but serious allergic reaction, as well as gastrointestinal problems, precluding the researchers from recommending its use as a hypertension treatment. Still, the study seems to justify further research into the biochemical causes of high blood pressure.
- read the Washington Post story
- see the study abstract for more
Related Articles:
New advances on hypertension
Can a vaccine control high blood pressure?
Drug-resistant hypertension a challenge
PKG key to controlling blood pressure
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: